Genomic differences selected through evolution may offer clues as to why COVID-19 outcomes vary widely

A team from the University of Pennsylvania analyzed genomic data from global populations, including thousands of ethnically diverse Africans, to identify genetic variants that may be associated with clinical COVID-19 outcomes.

Immunopathology, host-virus genome interactions, and effective vaccine development in SARS-CoV-2 - Computational and Structural Biotechnology Journal

Studies by Dolores Albarracin, Courtney Boen, Angela Duckworth

JCM, Free Full-Text

Genetic susceptibility to severe COVID-19 - ScienceDirect

The potential of genomics for infectious disease forecasting

Sex Differences in Immune Responses to Viral Infection

Postdocs Penn Today

In the News Penn Integrates Knowledge Professorships

Science Talk - Evolution, cancer and coronavirus – how biology's